Interleukin-5 (IL-5), a cytokine involved in eosinophil chemotaxis and activation, is felt to play an important role in lung eosinophil influx in asthma. As we have shown that eosinophil influx into the lung increases at night in nocturnal asthma (NA), we hypothesized that expression of IL-5 messenger RNA (mRNA) would be increased at night in subjects with NA. Methods: In an ongoing study, six subjects with NA, defined as an overnight fall in peak expiratory flow rate of > 15%, and 4 non-asthmatic controls underwent bronchoscopy with endobronchial biopsy at 4 pm and 4 am in a random order separated by one week. Expression of IL-5 mRNA was evaluated employing in situ hybridization using 35S labeled antisense and sense riboprobes. The number of epithelial and interstitial cells positive for IL-5 mRNA was determined by an individual blinded to asthma status. The number of positive epithelial cells was calculated as a percentage of the total number, and the number of positive interstitial cells was expressed as number/mm2. Results: IL-5 mRNA was expressed by epithelial and interstitial cells in both asthmatics and controls. There were no significant differences between the two groups in the number of IL-5 mRNA positive cells in both epithelial and interstitial cells at either time point. Within the NA group, the percentage of epithelial cells expressing IL-5 mRNA was higher at 4 am than 4 pm and this difference trended toward significance (12.4 1 3.2 vs. 5.2 1 2.6% at 4 am and 4 pm, p=0.06). Conclusions: Expression of IL-5 mRNA appears to occur in both large airway epithelial and interstitial cells of asthmatic and control subjects. In addition, expression of IL-5 mRNA trends toward increased expression at night in NA. Examination of IL-5 protein expression by epithelial cells in further studies with more subjects is necessary to confirm these present observations.

Project Start
1997-12-01
Project End
1998-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
37
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Millstein, Richard J; Pyle, Laura L; Bergman, Bryan C et al. (2018) Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 32:418-423
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Hayden, Kathleen M; Baker, Laura D; Bray, George et al. (2018) Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) 10:41-48
Shah, V N; Sippl, R; Joshee, P et al. (2018) Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int 29:733-739
Jensen, Thomas; Bjornstad, Petter; Johnson, Richard J et al. (2018) Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes :
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624

Showing the most recent 10 out of 1065 publications